Profile | GDS2987 / GI_38176293-S |
Title | Comparison of Rho kinase inhibitor and atorvastatin effects on primary cell lines |
Organism | Homo sapiens |
Sample | Title | Value | Rank |
---|---|---|---|
GSM214810 | HMVEC_vehicle_rep1 | ||
GSM215244 | HMVEC_vehicle_rep2 | 18.2 | 42 |
GSM215253 | HMVEC_vehicle_rep3 | 23.9 | 58 |
GSM215254 | HMVEC_atorvastatin_rep1 | 8.2 | 22 |
GSM215282 | HMVEC_atorvastatin_rep3 | 22.5 | 46 |
GSM215344 | HMVEC_atorvastatin_rep2 | 37.5 | 62 |
GSM215283 | HMVEC_atorvastatin_mevalonate_rep1 | 28.9 | 49 |
GSM215284 | HMVEC_atorvastatin_mevalonate_rep2 | ||
GSM215293 | HMVEC_atorvastatin_mevalonate_rep3 | ||
GSM215294 | HMVEC_SLx2119_rep1 | 9.5 | 33 |
GSM215295 | HMVEC_SLx2119_rep2 | 31 | 52 |
GSM215296 | HMVEC_SLx2119_rep3 | ||
GSM215297 | PASMC_vehicle_rep1 | ||
GSM215298 | PASMC_vehicle_rep2 | 25 | 37 |
GSM215310 | PASMC_vehicle_rep3 | 75.7 | 70 |
GSM215311 | PASMC_atorvastatin_rep1 | 89.5 | 73 |
GSM215312 | PASMC_atorvastatin_rep2 | 110.9 | 75 |
GSM215313 | PASMC_atorvastatin_rep3 | 156.7 | 78 |
GSM215324 | PASMC_atorvastatin_mevalonate_rep1 | ||
GSM215325 | PASMC_atorvastatin_mevalonate_rep2 | 7.6 | 15 |
GSM215326 | PASMC_atorvastatin_mevalonate_rep3 | 41.9 | 57 |
GSM215327 | PASMC_SLx2119_rep1 | 21.8 | 36 |
GSM215328 | PASMC_SLx2119_rep2 | 57.9 | 67 |
GSM215329 | PASMC_SLx2119_rep3 | 46.3 | 62 |
GSM215330 | Fibroblasts_vehicle_rep1 | 43.9 | 64 |
GSM215331 | Fibroblasts_vehicle_rep2 | 55 | 69 |
GSM215332 | Fibroblasts_vehicle_rep3 | 35.5 | 65 |
GSM215333 | Fibroblasts_atorvastatin_rep1 | 20 | 47 |
GSM215334 | Fibroblasts_atorvastatin_rep2 | 50.4 | 68 |
GSM215335 | Fibroblasts_atorvastatin_rep3 | 37.5 | 62 |
GSM215336 | Fibroblasts_atorvastatin_mevalonate_rep1 | 22.3 | 56 |
GSM215337 | Fibroblasts_atorvastatin_mevalonate_rep2 | 49.7 | 69 |
GSM215338 | Fibroblasts_atorvastatin_mevalonate_rep3 | 14.6 | 39 |
GSM215339 | Fibroblasts_SLx2119_rep1 | 62.1 | 71 |
GSM215340 | Fibroblasts_SLx2119_rep2 | 50.1 | 69 |
GSM215341 | Fibroblasts_SLx2119_rep3 | 62.8 | 71 |